ArticleNeurology(R) neuroimmunology & neuroinflammation2022
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.